Join the Oncology Voice Network. Join for Free
MSL Career Options: The transition from Field Medical to Medical Director
Medical Science Liaison Medical Director role career transition non-MD candidates post-COVID landscape

MSL Career Options: The transition from Field Medical to Medical Director


Share This Article


Summary

In this episode, Tom Caravela talks with Josh Corriveau about his journey from Medical Science Liaison to Medical Director. Josh shares insights into securing a medical director role and outlines the responsibilities involved. He discusses the essential skills and transferable competencies that facilitate this career advancement, emphasizing the importance of patient care. Josh addresses challenges faced by non-MD candidates and explores opportunities within the field. The conversation extends to the differences between in-house and virtual roles, highlighting the significance of scientific expertise. Josh concludes with advice for field medical professionals navigating the post-COVID landscape, encouraging strategic resourcefulness.

My guest today is Josh Corriveau, the Global Medical Affairs Director at Leo Pharma. We discuss the potential to make a career transition from MSL to Medical Director.

In this episode we discuss:

  • The transition from field medical to a medical director
  • How Josh got the job and the responsibilities as a medical director
  • What skills are mandatory to be considered for these types of roles
  • Many Medical Director roles require an MD, would he say it makes it a lot harder if you are a Ph.D. or PharmD?
  • His greatest challenges when transitioning into the Medical Director role
  • Are all Medical Director roles in-house or can some of these roles be field-based?
  • His advice to those in field medical transitioning out of COVID to field visit or hybrid of face to face and virtual interactions

Click for Source
Medical Science Liaison, Medical Director role, career transition, non-MD candidates, post-COVID landscape

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval
OVN Avatar Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Podcast
Hiring Managers Beware: Reverse Rejection Explained!
Partner Avatar Michael Pietrack

Hiring Managers Beware: Reverse Rejection Explained!

Article
The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates
OVN Avatar Jamie Riley

The Talent Inflection Point in Pharma and Biotech: A Challenge to Companies — and a Call to Candidates

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN